EuropaBio's response to the EU Pharmaceutical Strategy Consultation
Read our full response to the public consultation on the EU Pharma Strategy.
The European Comission is set to launch a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.
The strategy aims to adress the life cycle of medicines from R&D to authorisation and patient access; how to put scientific and technological advances into practice; how to fill market gaps (e.g. new antimicrobials) and lessons learnt from COVID-19 on how to better prepare for future pandemics.
You can download EuropaBio's full response to the public consultation on the EU Pharma Strategy below.